Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow Reinvestment Rate
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥487.63 Million (capex CN¥487.63 Million ) from operating cash flow of CN¥1.56 Billion. Explore 601607 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Shanghai Pharmaceuticals Holding Co Ltd across 27 annual periods. Also explore balance sheet size of Shanghai Pharmaceuticals Holding Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Shanghai Pharmaceuticals Holding Co Ltd. For live market cap and broader valuation context, see Shanghai Pharmaceuticals Holding Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥3.72 Billion | CN¥6.15 Billion | CN¥2.33 Billion | ▼ -37.4% |
| 2024 | 0.97x | CN¥5.62 Billion | CN¥5.83 Billion | CN¥2.40 Billion | ▼ -7.6% |
| 2023 | 1.04x | CN¥5.46 Billion | CN¥5.23 Billion | CN¥2.97 Billion | ▼ -67.3% |
| 2022 | 3.20x | CN¥15.16 Billion | CN¥4.74 Billion | CN¥2.68 Billion | ▲ +284.6% |
| 2021 | 0.83x | CN¥4.21 Billion | CN¥5.06 Billion | CN¥4.12 Billion | ▲ +49.0% |
| 2020 | 0.56x | CN¥3.82 Billion | CN¥6.84 Billion | CN¥3.01 Billion | ▼ -36.3% |
| 2019 | 0.88x | CN¥5.28 Billion | CN¥6.02 Billion | CN¥2.75 Billion | ▲ +6.1% |
| 2018 | 0.83x | CN¥2.59 Billion | CN¥3.14 Billion | CN¥1.94 Billion | ▼ -2.0% |
| 2017 | 0.84x | CN¥2.23 Billion | CN¥2.65 Billion | CN¥2.01 Billion | ▼ -67.3% |
| 2016 | 2.57x | CN¥5.01 Billion | CN¥1.95 Billion | CN¥2.12 Billion | ▲ +78.6% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | CN¥1.72 Billion | ▲ +49.0% |
| 2014 | 0.97x | CN¥1.29 Billion | CN¥1.34 Billion | CN¥1.29 Billion | ▲ +4.0% |
| 2013 | 0.93x | CN¥905.06 Million | CN¥973.45 Million | CN¥905.06 Million | ▲ +50.9% |
| 2012 | 0.62x | CN¥708.91 Million | CN¥1.15 Billion | CN¥708.91 Million | ▲ +164.0% |
| 2011 | 0.23x | CN¥413.54 Million | CN¥1.77 Billion | CN¥413.54 Million | ▼ -28.5% |
| 2010 | 0.33x | CN¥550.30 Million | CN¥1.69 Billion | CN¥550.30 Million | ▲ +171.1% |
| 2009 | 0.12x | CN¥79.97 Million | CN¥664.13 Million | CN¥79.97 Million | ▼ -62.0% |
| 2008 | 0.32x | CN¥90.50 Million | CN¥285.68 Million | CN¥90.50 Million | ▼ -19.4% |
| 2007 | 0.39x | CN¥192.29 Million | CN¥488.94 Million | CN¥192.29 Million | ▲ +51.3% |
| 2006 | 0.26x | CN¥151.60 Million | CN¥583.11 Million | CN¥151.60 Million | ▼ -90.4% |
| 2005 | 2.71x | CN¥198.09 Million | CN¥73.00 Million | CN¥198.09 Million | ▼ -34.2% |
| 2004 | 4.13x | CN¥254.38 Million | CN¥61.66 Million | CN¥254.38 Million | ▼ -98.8% |
| 2003 | 350.18x | CN¥169.58 Million | CN¥484.27K | CN¥169.58 Million | ▲ +12537.3% |
| 2002 | 2.77x | CN¥279.44 Million | CN¥100.84 Million | CN¥279.44 Million | ▲ +25.9% |
| 2001 | 2.20x | CN¥144.71 Million | CN¥65.73 Million | CN¥144.71 Million | ▲ +128.2% |
| 2000 | 0.96x | CN¥141.09 Million | CN¥146.22 Million | CN¥141.09 Million | ▲ +202.8% |
| 1999 | 0.32x | CN¥52.48 Million | CN¥164.67 Million | CN¥52.48 Million | — |